© 2021 MJH Life Sciences™ and Patient Care Online. All rights reserved.
Scott Harris
Articles
Intensive Program Extends Lifespan in T2D Patients
September 07, 2016
Results unequivocally support early, aggressive, and sustained risk factor control in patients with complicated type 2 diabetes.
New Diabetes Drugs May Also Improve Kidney Health
August 25, 2016
The renal protective effects seen with the SGLT2 inhibitor canogliflizin may be independent of glycemic control, suggest authors of a new post-hoc analysis.